2GAN WQ.senthilselvan A.Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis.Thorax,2004,59(7):574.
6Donaldson GC, Seemungal TA, Patel IS, et al. Airway and systemic infllammation and decline in lung function in patients with COPD. Chest,2005,128: 1995.
7MaurielloA,SangiorgiG,Palmieri G, et al .Hyperfibrinogenemia is associated with specific histocytologieal composition and complication of atherosclerotie carotid plaques in patients affected by transient ischemic attacks.Circulation,2000,101 (7) :744.
8CharlesTE.Crosstalk between inflammation and thrombosis.Maturitas, 2004,47:30.
9Sin D D.Man P S F.Why are patients with chronic obsuuotive pulmonary disease at Increased risk of cardiovascular diseases:the potential role of systemic Inflammafionin chronic obstructive pulmonary disease.Circulation,2003,107 ( 11 ): 1514.
10Wedzicha Ja. The herterogeneity of chronic obstructive pulmonary. disease .Thorax, 2000,55(8):631.
5SIN D D, MAN S F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease[J]. Circulation, 2003,107 (11) 1514-1519.
6MURPHY T F, SETHI S. Chronic obstructive pulmonary disease[J]. Drugs Aging, 2002,19 (10) : 761-775.
7EID A A, LONESCU A A, NIXON L S, et al. Inflammatory response and body composition in chronic obstructive pulmonary diseaserJ]. Am J Respir Crit Care Med, 2001,164(7) : 1414-1418.
9VINCENT J L. New therapeutic implications of anticoagulation mediator replacement in sepsis and acute respiratory distress syndrome[J]. Crit Care Med, 2000,28 (S9): S83-S85.
10DANL M, TYBJAERC-HANSEN A, VESTBO J, et al. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care-Med, 2001,164(6): 1008- 1011.
8MaccNee W.Oxidants/Antioxidants and chronic obstructive pulmonary disease:pathogenesis to therapy[J].Novartis Found Symp,2001,234:169-185.
9Kinnula V L,Llumets H,Myllarniemi M,et al.8-isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD[J].Eur Respir,2007,29(1):51-55.
10Gan W Q,Man S F,Senthilselvan A,et al.Association between chronic obstructive pulmonary disease and systemic inflammation:a systematic review and a meta analysis[J].Thorax,2004,59(7):574-580.
